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Invited Editorial
The pressing global concern of emerging antibiotic
resistance gripping masses and will affect millions
in future. Among several factors, accurate disease
diagnosis is an important cog in the machinery
driving antimicrobial resistance.
Keeping the context in consideration, as well as
the theme for this year’s National Health Sciences
Research Symposium, i.e. AMR, the theme for this
LABRAD edition is “Accurate disease diagnosis and
impact on Antimicrobial resistance (AMR)”.
In both paths i.e. laboratory and imaging, diagnostic
modalities are available at Aga Khan Hospital
laboratory and radiology department which

delineates infectious from non-infectious component,
guide therapeutic response, highlight variable
pathogenic process.
Our readers will find this edition very helpful by
reading not only about conventional methods but
also some novel diagnostic methods helpful in
identifying infectious disease diagnostic process.
“Diagnosis is not the end, but the beginning of
practice” – by Martin Fischer
Happy reading
Dr. Mohammad Zeeshan
Microbiology

Therapeutic Drug Monitoring for Antibiotics
in Infections
Dr. Siraj Muneer
Clinical Chemistry

Despite advances in contemporary medicine, severe
infections and sepsis-related mortality in critically
ill patients remain a global problem. Appropriate,
timely antibiotic therapy given at an adequate dose is
thought to be of paramount importance in improving
clinical outcome of severe sepsis. An important
consideration of antimicrobial treatment failure in
the critically ill is inadequate or sub-therapeutic drug
exposure.
This can be a direct consequence of pharmacokinetic
alterations due to the complex pathophysiologic
processes associated with severe infection.
Multi-drug resistant organisms more frequently
encountered in the critically ill also alter the dosing
requirements for these patients. Therapeutic drug
monitoring (TDM) is defined as the laboratory
measurement of drug serum concentration along
with adequate medical interpretation influencing the
management of drug therapy in patients.
TDM, has significance in improving patient outcome
and is utmost important in drugs with narrow
therapeutic index, drugs with high pharmacokinetic
variability, is being increasingly used for antibiotic
dose optimization in the attempt to improve
attainment of pharmacokinetic/pharmacodynamic

(PK/PD) targets and outcomes of severe infections
in the critically ill. TDM is a three step process
including:
(1) The precise and reliable measure of the
		 plasma concentration of a specific medicine;
(2) The interpretation of the obtained
		 concentration value according to the
		 knowledge on the concentration-effect
		relationship,
(3) The calculation and proposal of an individual
		 dose adjustment for that specific patient.
The appropriate indications for TDM include:
1. Avoiding toxicity
2. T adjust dose
3. To monitor patients for ineffective drug 		
		 treatment, non-compliance
In TDM, therapeutic range is used as a guide for
optimal drug concentration in serum, but this range
should not be considered as an absolute one. In certain
patients, drug effect will be evident even in case of
too low serum concentration, whereas other patients
will experience toxic effects, when drug serum
concentration is even in therapeutic range. Hence,
dosing of drugs should not be led only by serum drug
concentration, but by its clinical response as well.
3
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Table1: Therapeutic drug monitoring for antibiotics
Drug

Amikacin

Gentamicin

Vancomycin

Therapeutic Range

Sample Timing

Once daily dosea
Trough = <1.0 ug/ml
Peak = 56-64 ug/ml
Multiple daily dosea
Trough = 5-10 ug/ml

Sample
type

Sample
stability

Conventional dosing

Adults Multiple daily doseb
Peak: 4-10 ug/ml
Trough: 1-2 ug/ml
Adult Once daily doseb
Trough <1 ug/ml
Pediatrics trough concb
<2ug/ml
Therapeutic concentration levelc
>10 ug/ml
Complicated & Serious Infectionsc
15-20 ug/ml

Nephrotoxicity

Peak: 60–90 min after
i.m injection 30–60
Serum;
min after i.v. infusion EDTA
plasma
Trough: within 30
min of next dose

Trough: within 30
min of next dose
(should be obtained
prior to the fourth or
fifth dose).

Toxicity

Serum;
EDTA
plasma

2 h room
temperature;
freeze

Ototoxicity (Toxic
effects on the eighth
cranial nerve can result
in hearing loss, loss of
balance, or both)

2 h room
temperature;
freeze

Nephrotoxicity

Reference:
a: Sanford Guide to Antimicrobial Therapy (44th Edition 2014)
b: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, fifth edition
c: Therapeutic monitoring of Vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious
Diseases Society of America, and the Society of Infectious Diseases Pharmacists’, Am J Health-Syst Pharm. 2009; 66:82-98

Biomarkers of Sepsis
Dr Syed Bilal Hashmi and Ms Sana Arshad Mehmood
Clinical Chemistry

Sepsis is a clinical syndrome that has physiologic,
l
Temperature higher than 38°C (100.4°F) or
biologic, and biochemical abnormalities caused by
		 lower than 36°C (96.8°F)
l
Heart rate (HR) higher than 90 beats/min
dysregulated inflammatory response to infection.
l
Respiratory rate (RR) higher than 20 breaths/
It is caused by microbial invasion from a local
		 min or arterial carbon dioxide tension (PaCO2)
infectious source into the bloodstream which leads
		 lower than 32 mm Hg
to systemic inflammatory response syndrome
l
White blood cell (WBC) count higher than
(SIRS). The diagnosis of sepsis with high sensitivity
		 12,000/µL or lower than 4000/µL or with 10
and specificity is difficult, due to unspecific
		 percent immature (band) forms
manifestations and biochemical similarities to
noninfectious systemic inflammatory conditions.
Early diagnosis of sepsis
Table 1: Characteristics of ideal sepsis biomarker.
is necessary for earlier
Requisites for useful
Role of Biomarkers
intervention successful
Biomarkers
management and better
Objectively measured
Screening patients at risk of sepsis
patient outcome.
Criteria for sepsis are
considered to be met if at
least two of the following four
clinical findings are present:
4

Establish early diagnosis that helps the initial management of sepsis
Risk stratification to identify patients at risk of poor outcome
Monitoring the response of intervention
Predict outcomes

Ref: Infect Chemother 2014;46(1):1-12

Have reference standard
Have well-known kinetics
Reproducibility of test
Cost-effectiveness
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Biomarkers of Sepsis: A few biomarkers which
are well established for their use in sepsis include
CRP, ESR and Procalcitonin. Multiple studies have
reported their good correlation with the prognosis of
Sepsis, shown below.
1) C-Reactive Protein (CRP): The CRP was first
discovered in a patient with lobar pneumonia
in 1930 by Tillet & Francis. The CRP is a
protein produced in response to infection or
inflammation and it is widely used in clinical
tests to diagnose and manage patients with
sepsis. It is an acute phase reactant whose
synthesis in the liver is upregulated by
Interleukin-6. Its response is stronger in acutely
ill patients and levels decrease as patients
recover. It should be used cautiously in patients
with sepsis, as it is also a marker of inflammation
that also increases after surgery, burns,
myocardial infarctions, and rheumatic diseases.
The plasma half-life of CRP is 19 hours. The
sensitivity and specificity of CRP as a marker for
bacterial infections are 68–92 percent and 40–67
percent, respectively.
Its inability to differentiate bacterial infections
from noninfectious causes of inflammation makes
CRP of limited diagnostic value. However, CRP
shows promise for evaluating sepsis severity and
prognosis. CRP plasma levels have been shown
to correlate with the severity of infection. A
rapid decrease in CRP levels has been reported
to correlate with good response to initial
antimicrobial therapy in septic patients.
2) Procalcitonin (PCT): The PCT is a prohormone
of calcitonin and it is released by parenchymal
cells (liver, kidney, adipocytes, muscle cells) in
response to bacterial toxins, leading to increased
levels within two-four hours. In contrast, it is
down regulated in patients with viral infections.
It is a 116 amino acid protein with a molecular
weight of 14.5 KDa. The biological half-life
of PCT is 22 to 26 hours. The normal level of
PCT in the serum is low, less than, 0.1 ng/mL.
When bacterial infections occur, PCT is further
produced as a response to proinflammatory
stimulation. At present, PCT levels have been
used to guide empirical antibacterial therapy
in patients with acute exacerbations of chronic
bronchitis, community-acquired pneumonia and
sepsis. In a systematic review and meta-analysis,
PCT was found to be more specific (specificity
81 percent [95 percent CI: 67–90 percent]) than
CRP (67 percent [95 percent CI: 56–77 percent])
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for differentiating bacterial infection among
hospitalized patients.
This serum Procalcitonin is performed at
Aga Khan clinical laboratory and published
data from our center have shown that it is a
useful biomarker for monitoring prognosis of
sepsis patients, as well as identifying bacterial
infection.
3) Lactate: Lactate is a metabolite of glucose
produced by tissues in the body under conditions
of insufficient oxygen supply. Serum lactate
levels can reflect tissue hypoperfusion and
anaerobic metabolism in severe sepsis and septic
shock. Several studies have demonstrated that
elevated lactate levels are related to mortality
in patients with sepsis. In a large study of 1,278
patients with infections, those with lactate
levels above four mmol/L had higher in-hospital
mortality rates than patients with lactate levels
less than 2.5 mmol/L (28.4 percent vs. 4.9
percent). Recently, data from a retrospective
study by the Vasopressin Septic Shock Trial
and a single center septic shock cohort (St.
Paul’s Hospital cohort) have suggested that
even minimal increases in arterial lactate
concentration within the reference range (1.42.3 mmol/L) may predict 28-day mortality
(sensitivity and specificity of 86 percent and
27 percent, respectively). A study done at our
centre have reported that in comparison to PCT
and CRP, high plasma lactic acid levels are
associated with the development of all-cause
multiple organ dysfunction syndrome and worse
outcome in critically ill children admitted in
Pediatric intensive care unit.
4) New Markers of Sepsis: Apart from the 		
aforementioned biomarkers newer sepsis
related biomarkers are under research for clinical
use, including:
l
Soluble triggering receptor expressed on
myeloid cell one (sTREM-1) is a soluble
form of TREM-1, a glycopeptide receptor
expressed on the surface of myeloid cells
such as PMNs, mature monocytes, and
macrophages. TREM-1 expression increases
in bacterial or fungal infections.
l
Soluble urokinase plasminogen activator
receptor (suPAR) is a surface signaling
receptor expressed on most leukocytes.
l
Pro-Adrenomedullin (Pro-ADM) is
a 52-amino-acid peptide produced by the
adrenal medulla. ADM is produced during
5
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physiological stress
and has various
functions including
vasodilation and
anti-inflammatory
and antimicrobial
effects.
The diagnostic accuracy
of these markers is
shown in Table 2.

Table 2: Diagnostic Accuracy of Newer Biomarkers of Sepsis:
NPV

PPV

Type

0.87

70

86

Diagnostic

84

0.72

77

64

Prognostic

77
64

0.79
0.73

95
76

42
50

Diagnostic
Diagnostic

Biomarkers

cutoff/Range Sensitivity Specificity AUC

sTREM-1
(pg/mL)

40-755*

79

80

Pro-ADM
(nmol/L)

4.86

53

suPAR
(ng/mL)

10
8.9

80
66

Where AUC stands for ‘Area under curve’, PPV is ‘Positive predictive value’,and NPV is ‘Negative predictive value’
*Cut off point based in a meta-analysis of two studies.

Serum Procalcitonin Level - Biomarker of
Bacterial Infection
Zaib-un-Nisa
Clinical Chemistry

Procalcitonin (PCT) is the peptide precursor of
calcitonin, a hormone that is synthesized by the
parafollicular C cells of the thyroid and involved
in calcium homeostasis. Procalcitonin arises from
endopeptidase-cleaved preprocalcitonin. It is also
produced by the neuroendocrine cells of the lung
and intestine and is released as an acute-phase
reactant in response to inflammatory stimuli,
especially those of bacterial origin. It is a biomarker
that exhibit greater specificity than other proinflammatory markers (eg, cytokines) in identifying
sepsis and can be used in the diagnosis of bacterial
infections.

PCT levels intensify within two–four hours of
infection and the maximum level is reached by
six–eight hours and with continued infection or
sepsis the elevated level persists and decreases
once infection is controlled. PCT half-life is
about 20–24 hours. PCT levels persist as long
as the inflammatory process continues and the
level correlate with the severity of sepsis. The
applications or indications of testing PCT
include to:
l
Aid in the diagnosis and risk stratification of
		bacterial sepsis.
l
Aid in distinguishing bacterial from viral
		 infections, including meningitis.
l
Screen therapeutic response to antibacterial
		 therapy and reduce antibiotic exposure.
l
Aid the preference and timing of the 		
		 initiation of antibiotic treatment

The raised procalcitonin level during inflammation is
associated with bacterial end toxin and inflammatory
cytokines. Increased levels of serum procalcitonin
in response to viral infections and noninfectious
inflammatory stimuli such as autoimmune disease
and chronic
inflammatory Table 1: Interpretation of Procalcitonin Levels
Conditions Associated
processes are Test Name Reference Cutoffs
much less
l Localized mild-to-moderate bacterial infection
< 0.5 ng/mL represents a low
pronounced,
l Noninfectious systemic inflammatory response
risk of severe sepsis and/or
rarely
l Untreated end-stage renal failure
septic shock
exceeding
l Bacterial sepsis
0.5 ng/
Pro
l Severe noninfectious inflammatory stimuli 		
Calcitonin 2.0 ng/mL represent a high risk
mL. The
(e.g., major burns, severe trauma, acute
of severe sepsis and/or septic
reference
multiorgan failure, major abdominal or
shock.
cutoffs are
cardiothoracic surgery).
shown in
l Medullary thyroid carcinoma (may exceed
Table 1.
10,000 ng/mL).
6

(Procalcitonin
Algorithm) for
improved
antibiotic
stewardship.
The figure 1
shows
the algorithm
of PCT which
can be utilized
in antibiotic
therapy.

VOL. 45, ISSUE 3

OCTOBER 2019
l
Aid in the 		
		diagnosis
		 of systemic 		
		secondary
		 infection after 		
		 surgery and in
		severe trauma,
		burns, and
		multiorgan failure

Septic
shock

10ng/ml
Severe
sepsis

sepsis

2ng/
ml
0.5ng/
ml

PCT algorithm
for antibiotic
therapy

Local
infection

0.05ng/
ml
Serum PCT
level during
sepsis

>0.5ng/ml

Antibiotic
strongly
encouraged

0.250.5ng/ml

Antibiotic
encouraged

0.10.25ng/ml

Antibiotic
discouraged

<0.1ng/
ml

Antibiotic
strongly
discouraged

Figure 1: Algorithm for use of PCT for antibiotic Therapy. (taken from Vijayan et al. Journal of Intensive Care
(2017) 5:51; DOI 10.1186/s40560-017-0246-8)

Bone Marrow Findings in Malaria
Dr. Sana Brohi
Resident Haematology

Case: A 10-year-old boy presented with history
of fever, generalized weakness, weight loss and
recurrent nose bleed since 20 days. Physical
examination revealed pallor and palpable spleen
one-two cm. Bone marrow examination is done for
diagnostic workup.

the gametocytes in the background of trilineage
hematopoiesis with some dysplastic features (Figure 2).

CBC: Hb: 6.8 g/dL, WBC: 4.24 x 10E9/L, platelets:
16 x 10E9/L. Peripheral blood smear showed,
trophozoites, gametocytes and schizonts of
plasmodium vivax with parasitic index of 1.5
percent (Figure 1). Bone marrow aspirate showed

Figure 2: Bone marrow aspirate

Bone Marrow Findings in Malaria

Figure 1: Peripheral blood smear

Peripheral smear: In malaria, parasites are
seen within red cells. Malaria is associated
with hemolytic anemia, leucocytosis and
thrombocytopenia. The reticulocyte count may be
inappropriately low as a result of bone marrow
suppression.
7
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Bone marrow aspirate: Malaria parasites
are sometimes detected in red blood cells and
neutrophils, in bone marrow aspirate. In acute
falciparum malaria, the bone marrow may be
hypocellular, normocelullar, or mildly hypercellular.
Erythropoiesis is usually suppressed. In chronic
falciparum malaria, there is hypercellularity with
erythroid hyperplasia, increased lymphocytes,
plasma cells and macrophages. Haemophagocytosis
and macrophages can also contain malarial pigments.
Bone marrow in Plasmodium vivax malaria is
also characterized by dyserythropoiesis, increased
macrophages (some showing haemophagocytosis)
and plasma cells. In hyper-reactive malarial
splenomegaly, there may be a marked increase in

bone marrow lymphocytes.
Bone marrow trephine histology: Bone marrow
biopsy in malaria usually shows increased cellularity
and increased macrophage activity, often with
haemophagocytosis. During acute attacks of malaria,
sinusoids may be packed with parasitized red cells.
In patients who have suffered recurrent attacks of
malaria, the bone marrow may be slate grey or black
due to deposition of malaria pigments. It is important
to distinguish malaria pigment (haemozoin) from
formalin pigment. Haemazoin is found not only
in macrophages but also within erythroid and
granulocytic precursors, possibly contributing to
dyserythropoiesis and erythroid suppression.

Post-Splenectomy Care and Anti-Microbial
Prophylaxis
Dr Hareem Alam
Hematology

Spleen mediates important
immunologic and hematologic
functions as well as contribute
to numerous pathological
ELECTIVE
processes. Surgical removal
of the spleen results in reduced
clearance of particulate
At least 2 weeks preantigens [extracellular (e.g.
operativey
bacteria) or intracellular (e.g.
malaria)], diminished response
to new antigens, particularly
l Pneumococcal PPV 23
vaccine
polysaccharides and impaired
l Children <2 years
phagocytosis of un-opsonized
Pneumococcal 7 Valent
vaccine
and opsonized bacteria and
l Haemophilus Influenza B
cells. Asplenic individuals
l Meningococcal C vaccine
are particularly vulnerable to
sepsis caused by bacteria and,
occasionally, protozoa. Such infections are often
fulminant, with high mortality. Splenectomy usually
is performed in two major clinical scenarios: trauma
and hematologic diseases including hereditary
hemolytic anemias and autoimmune cytopenias.
Auto-splenectomy may occur in sickle cell anemia.
Infections: Overwhelming post-splenectomy
infection is usually caused by the encapsulated
bacteria Streptococcus pneumoniae, Haemophilus
influenzae, and Neisseria meningitidis. Other
8

SPLENECTOMY

EMERGENCY

Immediate post-operative
period

l
l

Pneumococcal PPV 23
vaccine
Children <2 years
Pneumococcal 7 Valent
vaccine

At least 2 weeks postoperatively

l

Haemophilus Influenza B

l

Meningococcal C vaccine

pathogens may include Escherichia coli,
Pseudomonas aeruginosa, Capnocytophagia
canimorsus, group B streptococci, Enterococcus
species, Ehrlichia species and protozoa such as
Plasmodium species leading to malaria.
Predisposing risk factors: The main risk factors
for infections include: the age at which splenectomy
is performed, children are particularly at risk, the
reason for splenectomy, and the time interval from
splenectomy (most infections occur within two years).

OCTOBER 2019

Post-splenectomy care: Guidelines published
by the British Committee for Standards in
Haematology emphasized that most infections after
splenectomy could be avoided through measures
that include offering patients appropriate and timely
immunization, antibiotic prophylaxis, education, and
prompt treatment of infection.
Time of Vaccination: For patients undergoing
splenectomy, vaccines should be given at least 14
days prior to the procedure when feasible. When
vaccines cannot be given in this time frame, they
should be given 14 days after splenectomy.
Antibiotic prophylaxis: Lifelong prophylactic
antibiotics should be offered to patients considered
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at continued high risk of pneumococcal infection
either with penicillin V or amoxicillin. Factors
associated with high risk of invasive pneumococcal
disease in hyposplenism include: age less than
16 years or greater than 50 years, inadequate
serological response to pneumococcal vaccination, a
history of previous invasive pneumococcal disease,
and splenectomy for underlying hematological
malignancy particularly in the context of on‐going
immunosuppression.
Patient education: It is important that the
patient should be well informed and educated
about infectious risks associated with history of
splenectomy, and understands the steps that must be
taken prior to splenectomy.

Invasive Fungal Infections in Hematological
Malignancies
Dr Jyoti Mohan Lal
Hematology

The control of bacterial infections in patients with
hematological malignancies has been significantly
improved with broad-spectrum antibiotics in the past
decades however, treating invasive fungal infections
(IFIs) is still a major problem in these patients,
especially in patients with prolonged neutropenia
after chemotherapy. The incidence of invasive fungal
infections has dramatically increased over the past
several decades, and the majority of these infections
are in patients with hematologic malignancies
(HMs). They remain a leading cause of morbidity
and mortality in this population, especially among
patients with acute myeloid leukemia (AML) and
those who have undergone allogeneic hematopoietic
stem cell transplantation.
Common organisms: Candida and Aspergillus
species are the most common recognized causes of
IFIs in patients with hematological malignancies.
However, other typically less common yeasts
and filamentous fungi e.g., Blastomyces spp.,
Cryptococcus spp., Trichosporon spp. and
Zygomycetes) are emerging in patients with HMs
as significant human pathogens, frequently as
breakthrough infections in patients receiving empirical
antifungal therapy or antifungal prophylaxis.

Risk factors: Among the most important patientrelated factors is the underlying fitness or
functionality of the patient. Many studies have
shown that older patients (≥60 years) with AML or
myelodysplastic syndrome (MDS) with preexisting
cytopenias have an increased risk of fungal
infections because their innate immune system is
weakened. Frail patients, who are more likely to
be older are thought to have a higher risk. Another
risk factor is the type of therapy administered for
the underlying leukemia. Compared with patients
with acute leukemia and hematopoietic stem cell
transplant (HCT) recipients, the risk for invasive
fungal infections is lower in patients with chronic
leukemias, lymphoma, and multiple myeloma, but
invasive fungal infections do occur in such patients.
Prognosis: Studies have shown that the mortality
associated with invasive fungal infections in
patients with AML undergoing induction therapy,
autologous stem cell transplant, or allogeneic stem
cell transplant may be as high as 40 percent to 60
percent, as compared with approximately 20 percent
among patients treated with less-intensive or lessmyelosuppressive therapy.

9
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Following factors have been identified that
negatively influence the outcome of IFI:
l
old age,
l
use of corticosteroid
l
an absolute neutrophil count (ANC) of less
		 than 0.1X109/L at the time of IFI diagnosis
l
lack of recovery from aplasia and
l
multiple pulmonary localizations of infection
Clinical presentation: The most common
presentation of a leukemia patient with a fungal
infection is a neutropenic fever of unexplained
etiology. Typically, patients who develop a
neutropenic fever will initially begin treatment with
broad-spectrum antibiotics. A fever that persists
without a clear source should prompt consideration
of a systemic fungal infection, with the appropriate
diagnostic workup. The second most common
presentation of a fungal infection is pulmonary
infection, such as pneumonia, and sinusitis. The third
most common presentation is disseminated infection,
manifested commonly as skin lesions or soft tissue
involvement, particularly in patients with systemic
Candida infections or disseminated candidiasis.
Lastly, infections may also be identified through a
routine blood culture.

Diagnostic tool: Monitoring patients during aplasia
includes history and physical examination, daily
blood counts, serum C-reactive protein (CRP) and
serum Galactomannan index (s-GMI) thrice-weekly.
For febrile neutropenia (FN), an infectious disease
workup is performed and intravenous broadspectrum antibiotics are started. Additional workup
is obtained for antibiotic-refractory FN, including
chest CT even in the absence of pulmonary findings.
Patients with negative serum fungal biomarkers but
with radiologic findings suggestive of IFI should
undergo bronchoalveolar lavage (BAL), with testing
of BAL fluids for fungal biomarkers.
Blood cultures have moderate sensitivity for
hematogenous infections with yeasts and
molds with adventitious sporulation but have
no sensitivity for invasive aspergillosis (IA).
Cultures, stains, and histopathology with direct
examination of involved sites can be diagnostic
(e.g., metastatic skin lesions of candidiasis,
trichosporonosis and fusariosis).
Detecting circulating serum 1,3-β-D glucan (s-BDG)
may be useful in diagnosing various IFIs, including
candidiasis, aspergillosis, fusariosis and others.

Antibiogram: A Clinicians’ Reference for
Antibiotic Selection
Noureen Saeed
Instructor Microbiology

An antibiogram is a summary of antimicrobial
susceptibilities of bacterial pathogens that are
reported by a clinical microbiology laboratory in an
institute during a specific time period. Due to the
emerging resistance patterns, this important tool
guide clinicians in deciding empiric therapy in view
of prevailing susceptibility trends against a specific
pathogen. Apart from this it can be used to track
the evolving antimicrobial resistant trends across
different units of the hospital.
Antibiograms usually represent a cumulative
report of an institution, however, it can further be
segregated according to different important clinical
units e.g. Intensive care units (MICU, SICU, NICU,
PICU). Therefore, it could also be affective in
evaluating the infection prevention practices by
10

monitoring specific drug resistance pattern in any
surveillant hospital unit. It could also be use as an
important antibiotic stewardship tool. This important
document is institute specific data and cannot be
generalizable to other institution.
Antibiogram Preparation
1.
		
		
		

Responsibility: Clinical microbiologist are
responsible for preparing the antibiogram
based on antimicrobial Susceptility testing
data generated from microbiology laboratory

2.
		
		
		

Reliability of Antibiogram: An institution
antibiogram is not a true reflection of its
resistance trends unless reporting of
microbiology culture results are accurate
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according to international guidelines.
Clinical Laboratories Standards Institute
(CLSI) and European Committee for
Antimicrobial Susceptibility Testing
(EUCAST) provide guidelines about
performance methods, incubation,
quality control and recommended
antimicrobial agents against each organism
group. Guideline document for antibiogram
preparation M39-A4 by CLSI is
also available and gives specific
recommendations on different
variables included in preparation of
antibiogram, these includes minimum
number of isolates to be tested for reporting
in an antibiogram, frequency of reporting,
exclusion of screening isolates from
antibiogram, and which antimicrobials to test.

		
		

duplicate removal is an uphill task and must
be done meticulously.

3.
		
		
		

Frequency of antibiogram preparation:
Generally, it is recommended to have it at
least annually or it could be biannually
depending upon institutions’ workload.

4.
		
		
		
		
		

Organisms’ selection criteria: Bacteria
which have significant available data and
frequently isolated from a laboratory must be
selected and reported in an antibiogram,
otherwise data may be skewed and would
not be representative. Data filtration and

1. Quality of antibiogram is directly related to
		 the quality of patient’s reports. If colonizers
		 or other organisms are reported which are
		 not true pathogens this may yield a low
		 quality antibiogram with misleading
		information.
2. It shouldn’t be used solely to make clinical
		 decisions about antimicrobial therapy
3. Antibiograms do not reflect the synergistic
		 effects of antibiotics which are used in
		combinations

5. Using Antibiogram: It is better to have
		 uniformity in reporting the final data every
		 year. CLSI has recommendation for
		 reporting it in percentage susceptible.
		 Segregation of data according to the units
		 can be very effective in antibiotic selection
		 in view of available data of the specific 		
		area.
6.
		
		
		

Accessibility: Pocket size printed version of
antibiogram should be available at every
ward, nursing stations. It could be uploaded
in hospital’s websites for ready reference.

Limitations

Note: Susceptibility profiles are derived from all specimen received by the Clinical
Microbiology Laboratory. Antibiotic susceptibilities of bacteria recovered from
specific wards or populations may differ.

Figure 1: Template of an antibiogram

Pakistan Antimicrobial Resistance Network
(PARN)
A detailed module on antibiogram, preparation
and its use is available at Pakistan antimicrobial
resistance network (PARN) website which is

available at
http://parn.org.pk/course-list/Antibiograms of
various institutions is also available at PARN website
http://parn.org.pk/antimicrobial-data/
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Antimicrobial Susceptibility Testing (AST):
Best Practices, Better Outcome
Shireen Shahid
Microbiology
Adversity of antimicrobial resistance has started to
affect the mankind since its inception and now it
has become a brute force against the humanity. It
is substantive responsibility of treating physicians
to confirm susceptibility of chosen empirical
antimicrobial agents. There is also important
obligation of clinical microbiology laboratories
to detect resistance in individual microbes using
methods which are reproducible and reliably.
Empirical therapy continues to be effective for
some bacterial pathogens because resistance
mechanisms have not been observed e.g.,
continued penicillin susceptibility of Streptococcus
pyogenes. Susceptibility testing is important
with microorganisms that may possess acquired
resistance mechanisms (e.g. members of the
Enterobacteriaceae, Pseudomonas species,
Staphylococcus species, Enterococcus species, and
Streptococcus pneumoniae).
The phenotypic methods for AST in a clinical
microbiology laboratory are:
1. Disc diffusion (DD) method
2. Minimal inhibitory concentration (MIC)
		methods
		 i. Microbroth dilution (MBD)
		 ii. Gradient strip (e-test)
		 iii. Automated instrument systems (e.g.
			Vitek, MicroScan).
A

B

C

of the specific laboratory method but also ensure
its validation and documentation. In this way the
retrospective tracing of an incidence that cause an
erroneous result become feasible for a laboratory
manager.
Quality Management (QM) in AST
A microbiology laboratory manager, who is
responsible for a reliable AST results, can only
deliver by vigilant monitoring of essential quality
management components which are elaborate below.
1. Staff: a motivated staff is the back bone of
quality process. Competency can be achieved with
the nexus between motivation and proper training.
Learning objectives and methods of training must
be clear. Evaluation of staff performance done by
regular competency assessments, internal audits and
external proficiency testing. Feedback process to the
staff is a vital for bringing the improvement.
2. Standard operating procedures (SOPs): It is
a compilation of step-by-step instruction that help
workers to carry out complex routine operations.
For AST, the SOP must adhere to international
guidelines e.g. Clinical Laboratory Standardization
Institute (CLSI) or European Union Chemotherapy
and Antimicrobial Susceptibility Testing (EUCAST).
Department committee for AST procedure
must monitor any recommended changes in the
aforementioned documents
D
and also ensure to update and
implement it in the laboratory
SOP.

3. Policy: It is a plan of what
to do in a particular situation
that has been agreed officially
by a group of people. For
AST, manager must form
a
committee comprises of
Figure 1: AST Methods A: Disc diffusion. B: Broth microdilution. C: Gradient strip D: Automated instrument
senior technical staff members
who responsibilities would be development and
Getting the reliable results in a laboratory
implementation of policies in view of recent
is conditional to the adherence with quality
therapeutic and diagnostic recommendation. For
management and quality assurance practices.
smooth running of process this committee must
Quality assurance process not only describe step
12
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keep in their consideration inventory management
policies. Manager ensure that the policies must
disseminate, read and followed by all technical staff.
4. Documentation: “Not documented, Not
done”. This canonical saying is the basis in quality
management. It’s not enough that they do it well but
they should also have to show it in the documents
e.g. maintenance forms. They have to document
instrument performance and maintenance, daily
good laboratory practices, results of quality control
activities. Technical staff must be sensitized and
trained in documenting what has happened in
laboratory and the activities performed by them. This
can help to trace back the information whenever if
required. These documents must have some schedule
reviewing process by the manager.
They must ensure daily prompt and proper
documentation of quality control activities of AST
and “root cause analysis” of errors must have done
properly in order to avoid the repetition of that
specific incidence.
5. Validation: Before implementing new method
of susceptibility testing (e.g. disc diffusion to broth
microdilution) it must be validated for the intended
results.
6. Verification: Reagents, media and antibiotics
use in AST must be verified before use at time of
different shipments or after receiving a new lot.
7. External quality assessment: this can help in
assessing the technical skills of technologist and also
evaluate the processes of any laboratory test. For
example, proficiency tests by College of American
Pathologist (CAP) and UK NEQAS microbiology.
Quality Assurance (QA) in AST:
The objective of QA in AST is to maintain the
standardization and quality of the data. Any
deviation could cause faulty outcomes in the form of
patient’s morbidity and mortality and promotion in
antimicrobial resistance.
QA can be achieved through quality control (QC)
and the goals of QC are to monitor:
a. The precision and accuracy of AST
		procedure
b. The performance of reagents in the test
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c. The performance of technical staff who
		 perform and read the test
The goals are best achieve-but not limited toby testing the quality control strain. QC strains
are well characterized organisms with defined
susceptibility or resistance mechanisms to the
antimicrobial agent(s) tested e.g. American
Type Culture Collection (ATCC). Maintenance,
storage and logging of these strain is critical and
therefore senior staff must be responsible for this
activity.
Standardization in performance is vital and factors
that can influence the results of AST are:
i. Size of inoculum
ii. Content of the acidity (pH) of the media
iii. Cation content (Ca2+, Mg2+)
iv. Incubation time and temperature
v. Reading procedure
Moreover, for diffusion methods:
vi. Diffusion rate of antimicrobial into the agar
vii. Depth and dryness of the agar
viii. Microbial growth rate
Reliable and reproduceable results => standardize
method + quality assurance.
Following are the examples of International guideline
that describes the methods (DD, MIC) in detail about
media, inoculation, incubation etc.
• ISO (International organization for
		standardization)
• CLSI (Clinical and Laboratory Standards
		Institute- www.clsi.org)
• EUCAST (The European Committee on
		 Antimicrobial Susceptibility Testing –
		www. eucast.org)
For training of a new staff in AST and its quality
control, laboratory manager can refer to www.parn.
org.pk. This website provides free online course
of AST, quality control, specimen processing and
biosafety in 7 different modules. After module
completion they will be assessed and graded.
If good laboratory practices (GLP) and compliance
with quality management for AST is vigilantly
followed by laboratory personnel, reliable
antimicrobial susceptibility result can be generated
and that help clinician in selecting right antibiotic
and hence contribute in reducing antimicrobial
resistance (AMR).
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Parasitological Diagnosis of Malaria Using
Rapid Diagnostic Test (RDT)
Dr Moiz Khan
Microbiology

The theme for World Malaria Day 2019, “Zero
malaria starts with me”, suggests this hope and
emphasises country ownership and community
empowerment for malaria prevention and care in
Pakistan.
Malaria is a life-threatening disease. According to
an estimate 6.8 million people are died with malaria
globally since 2001. The situation in Pakistan is
also grave and roughly 60 percent of Pakistan’s
population, live in malaria endemic regions.
In a recent study, it is noticed that Khyber
Pakhtunkhwa is the most malaria-affected province
of Pakistan as compared to the other three provinces
i.e., Punjab (2.4 percent), Sindh (10.8 percent) and
Baluchistan (3.8 percent).

Figure 1: Sample sites and distribution of Plasmodium species across
Pakistan.

According to WHO guidelines, parasitological
diagnosis is required for confirmation of the clinical
diagnosis of malaria. It is recommended for all
suspected malaria cases in all transmission settings.
The advantages of parasitological diagnosis are:
a) improved care of parasite-positive patients
		 owing to greater certainty that the cause of
		 the present illness is malaria;
b) identification of parasite-negative patients
		 for whom another diagnosis must be sought;
c) prevention of unnecessary use of anti		 malarial, thereby reducing the risk of adverse
		 side effects and drug interactions;
14

d) confirmation of treatment failures; and
e) improved malaria case detection and
		reporting
Parasitological diagnosis should be available
within a short time (less than two hours) of clinical
examination of the patient. If this is not possible, the
patient should be treated on the basis of a clinical
diagnosis.
The two main methods in routine use for
parasitological confirmation of malaria are light
microscopy and rapid diagnostic tests (RDTs).
For the management of a new fever episode, qualityassured microscopy and RDTs are equivalent
in terms of performance for the diagnosis of
uncomplicated malaria. In addition, molecular
diagnosis (e.g. polymerase chain reaction / PCR)
is usually applied in research settings, and in
surveillance in areas where elimination of malaria
is in progress. Serological tests for malaria have no
place in the management of febrile patients.
In settings of low to moderate and/or unstable
transmission and the low transmission season in
areas with seasonal malaria, health workers should
be trained to identify, through the case history,
patients who have been exposed to malaria risk
before a parasitological test is ordered.
Malaria species identification: in areas where
two or more malaria species are common, either
malaria microscopy or certain RDTs can provide
a species-specific diagnosis. Where P. falciparum
and non-falciparum malaria are both prevalent and
commonly occurring as single-species infections,
if microscopy is not available, it is recommended
to use combination RDTs that detect all species
and distinguish P. falciparum and non-falciparum
malaria.
In epidemic-prone zones, good quality malaria
diagnosis must be available, not only for case
management but also for surveillance, i.e. investigation
of an unexpected increase in cases of fever.
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During outbreak investigations and field surveys,
RDTs have the advantage of allowing both detection
and immediate treatment of malaria-positive cases.
When the positivity rate is very low, it becomes
difficult to maintain the interest and skills of
microscopist and their capacity to implement an
effective quality management system based on slide
cross-checking (because of problems of sensitivity).
In complex emergency situations, there are several
logistic and practical advantages to using RDTs
rather than microscopy: rapid deployment in the
field, less training needed than for microscopy, no
need for an electricity supply, immediate availability
of results for treatment of positive cases in the field,
and potential for testing more cases. However, if the
patient has received previous antimalarial treatment, a
microscopic examination of blood film for malaria is
recommended to investigate possible treatment failure.
Rapid diagnostic tests (RDTs) that are accurate,
relatively inexpensive and can be used in field
conditions make this possible. Use of antigen
detecting rapid diagnostic tests (RDTs) is a vital
part of this strategy, forming the basis for extending
access to malaria diagnosis by providing parasitebased diagnosis in areas where good-quality
microscopy cannot be maintained. The number
of RDTs available and the scale of their use have
increased rapidly over the past few years; however,
limitations of field trials and the heterogeneous
nature of malaria transmission have limited the
availability of the good-quality data on performance
that national malaria programmes require to
make informed decisions on procurement and
implementation.
Therefore, in 2006, WHO special programme for
research and training in tropical diseases (TDR)
and the foundation for innovative new diagnostics
(FIND) launched a programme to systematically
evaluate and compare the performance of
commercially available malaria RDTs. The RDT
product testing has undergone 6 rounds of testing
from 2008 to 2015 and the results have been
published annually since 2009.
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In each round of testing, products were evaluated
against geographically diverse, cryopreserved
plasmodium falciparum and plasmodium vivax
clinical samples diluted to 200 and 2000 parasites/μL
with consistently comparable concentration ranges of
histidine-rich protein ii (HRP-2), plasmodium lactate
dehydrogenase (pLDH) and aldolase determined by
quantitative enzyme-linked Immunosorbant assay
(ELISA). The former is well below the mean parasite
density found in many populations with endemic
malaria and is considered close to the threshold that
must be detected in order to reliably identify clinical
malaria in many settings. The aim of the evaluation
is to provide comparative data on the performance of
the submitted production lots of each product.
The results in this report show the comparative
performance of RDTs and indicate which
products are likely to be more sensitive in the
field, particularly in populations with low-density
infections. The performance of the products varied
widely at low parasite density (200 parasites / μL)
and all products had a high rate of detection of
falciparum at 2000 or 5000 parasites/μL, as did the
majority of products for vivax at 2000 parasites/
μL. However as stated previously a low parasite
density (200 parasites/μL) is considered close to the
threshold that must be detected in order to reliably
identify clinical malaria in many settings.

Figure 2: Rapid Diagnostic Kits (RDTs) for diagnosis of malaria
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Laboratory Diagnosis of Meningitis
Dr Salima Rattani
Microbiology
In clinical practices suspicion of meningitis
requires laboratory evaluation and confirmation.
This in essential as it can influence the therapeutic
management by selecting appropriate antimicrobial
agents. Impact of inadequate laboratory diagnosis
of meningitis is multifaceted as it increases the
morbidity and mortality, promote antimicrobial
resistance and increase financial cost on patient.
In community acquired meningitis the etiological
agents could be bacterial, fungal, mycobacterial,
viral and parasitic. These could be endogenous flora
of susceptible host but could also be from exogenous
sources e.g. environmental, water and animals
especially in case of immunocompromise scenario.
In health care setting it is usually from exogenous
sources e.g. of hospital environment and transmit
through indwelling devices.
Aseptic meningitis is the presence of clinical and
laboratory evidence for meningeal inflammation
with negative routine bacterial cultures. Enterovirus
is the commonest cause of aseptic meningitis.
Other viral causes include Herpes simplex type I

(HSV I), Herpes simplex type 2 (HSV 2), EpsteinBarr virus (EBV), Varicella-zoster virus (VZV),
Measles, Human immunodeficiency virus (HIV),
Cytomegalovirus (CMV), Adenovirus, Arboviruses,
Coxsackieviruses types A and B, Echoviruses,
Influenza A and B.
Aseptic meningitis has a self-limited course that
will resolve without specific therapy whereas
bacterial meningitis is life threatening and requires
prompt administration of antibiotics. Whenever
a patient is suspected of having meningitis, it is
advised to obtain cerebrospinal fluid and blood
for cultures and susceptibility and start empiric
treatment according to common causative agents
in that particular age group. However, specimen
collection after initiating antibiotic therapy may
cause sterilization of CSF and lead to negative
culture results. This leads to an inability to properly
tailor therapy in view of culture and susceptibility
findings.
The following table represents CSF findings in
different kinds of meningitis.

Table 1: Typical CSF Parameters in Patients with Meningitis
Protein level
in mg per dl (g
per l)

Likelihood of
observing organism
on CSF stain

Normal

< 200
(2.00)

Not applicable

> 80

Low

> 100
(1.00)

~70%

> 100
(0.10)

~50

Normal

> 50
(0.50)

~30%

Partially treated
pyogenic

> 100

~50

Normal

> 70
(0.70)

~60%

Tuberculous

50 to 500 (0.05 to
0.50)

< 30

Low

> 100

Rare

Fungal

50 to 500

< 30

Low

Varies

high in
cryptococcus

Pathogen

White blood cells per
μl (× 109 per l)

Percentage of
neutrophils

Aseptic, often
viral

10 to 1,000 (0.01
to1.00)

Early: > 50
Late: < 20

Pyogenic

> 500
(0.50)

L. monocytogenes

Apart from CSF analysis and culture and sensitivity
testing, serological and molecular techniques
16

Glucose level

against etiological agents of community associated
meningitis.
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Table 2: Serological and molecular diagnostic techniques against agents of community associated meningitis:
TEST

ORGANISMS

Latex Particle Agglutination (LPA)

l

l

Streptococcus group B
Haemophillus influenzae type b
Streptococcus pneumonia
Neisseria meningitidis (groups A, B, C, Y, W135)
Escherichia coli K1

Cryptococcal Antigen Test (CAT)

l

Cryptococcus neoformans

CSF GeneXpert for TB and TB culture

l

Mycobacterium tuberculosis complex

CSF PCR for Primary amoebic
meningoencephalitis (PAM)

l

Naegleria fowleri

CSF FilmArray (PCR based test) Meningitis/
Encephalitis Panel (BFM)

Bacteria
l Streptococcus agalactiae (GBS)
l Haemophillus influenzae
l Streptococcus pneumonia
l Neisseria meningitides (encapsulated)
l Escherichia coli K1
l Listeria monocytogenes
Viruses
l Cytomegalovirus (CMV)
l Enterovirus
l Herpes simplex type I (HSV I)
l Herpes simplex type 2 (HSV 2)

l
l
l

l
l
l
l

The utility of the above-mentioned diagnostic tests
is essential for better patient’s outcome as it not
only strengthened the diagnostic and prognostic

Varicella-zoster virus (VZV)
Human parechoviruses
Human Herpesvirus 6 Yeast
Cryptococcus neoformans/ gattii

capabilities and but it can also be utilized for
implementing antibiotic stewardship.
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Methods of Diagnosing Entamoeba histolytica,
Giardia lamblia, and Echinococcus granulosus in
A Routine Diagnostic Laboratory
Nadia Zehra
Clinical Microbiology

Global burden of parasitic disease affecting human
species is significant. Using the disability-adjusted
life year (DALY) as a metric, human parasite also
cause an enormous disease burden with more than
100 million DALYs annually by some estimates.
This value exceeds the global disease burden from
HIV-AIDS. Despite their public health importance,
most of the human parasitic diseases have been
neglected by the scientific, medical, and public
health communities. Their neglect stems from the
observations that parasitic diseases generally occur
among the poor, and more often than not occur in
remote and rural areas where they are hidden from
view. Moreover, parasitic diseases not only occur
predominantly in the setting of poverty, but often
because they result in chronic disability, they are
themselves poverty-promoting.
The aforementioned crucial situation necessitates
clinical microbiology laboratories to have diagnostic
options in their repertoire against parasitic infections.
This will help to get the best of both worlds by
minimizing the antibiotic use and initiating the
targeted anti-parasitic drugs.
Entamoeba histolytica and Giardia lamblia are the
most important diarrhea-causing parasitic protozoa.
Echinococcus granulosus is a tissue invasive
parasites (larval Cestodes) that invade the major
tissues and organs of the human body and cause
a major disease called Echinococcosis (cystic
hydatid) disease. Humans are accidental deadend hosts.
For the diagnosis of diarrheagenic protozoal
parasites (E. histolytica, G. lamblia),
microscopic examination of fecal specimen
in saline and iodine preparation using
concentration technique is still the most
commonly used method in resources limited
diagnostic settings. Permanent stain smear
(e.g. Giemsa stain preparation) can improve
the sensitivity of microscopic method. Due
to its dependence on the technical skill
of laboratory personnel, the probability of
18

misdiagnosis is prevailing. Apart from technical
skills, presence of a smaller number of pathogens
in the specimen is also an important limitation for
early diagnosis of enteric protozoa.
Echinococcal disease manifest as mass lesion
affecting multiple body sites. Radiological evidence
followed by excystation and visualizing hooklets
under microscope.
Diagnostic limitations necessitate the need of
alternative methods which could be affective, reliable
and early diagnose these important parasitic diseases.
Available modalities include serological methods e.g.
Enzyme-Linked Immunosorbant Assay for antibody
and antigen (ELISA), Direct Fluorescent-Antibody
Assay (DFA), immunochromatography test (ICT)
and molecular methods e.g. PCR.
The diagnostic facilities available in microbiology
section of Aga Khan Hospital Laboratory for
the detection of E. histolytica, G. lamblia and E.
granulosus are as follows:

		
		
		
		

		

Fecal wet mount and concentration methods
with trichrome stain for confirmation of both
the Giardia lamblia and E. histolytica are
classical tests, popular due to their standing
as gold standards.
Antigen detection by ELISA is highly
sensitive and specific for Giardia lamblia in

Figure 1: Giardia lamblia, cyst and trophozoite, stained with trichrome.
(Picture courtesy: Mr. Ferozuddin Zaheeruddin, senior technologist- microbiology
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		 a single fecal sample. While microscopic
		 method for the detection of organism need at
		 least 3 samples to be examined.
 Serologic tests such as IgG antibody
		detection by ELISA against E. histolytica
A

Figure 2: A: ELISA plate with microplate;

		 and is important to distinguish amoebic
		 from bacterial liver abscess. For
		Echinococcus it is intended for non-invasive
		 diagnosis of hydatid cyst.

B

B: ELISA reader

Detection of Pneumocystis jirovecii by PCR
Dr Safia Moin
Microbiology

Pneumocystis pneumonia (PCP) is an opportunistic
infection in immunocompromised patients,
particularly those with HIV infection, in patients
with transplants, those receiving corticosteroids and
other immunosuppressive agents. The causative
agent, Pneumocystis jirovecii, previously misnamed
as Pneumocystis carinii is an atypical fungus. PCP is
still a major cause of morbidity and mortality among
HIV/AIDS patients and constitutes a worldwide
problem. While the incidence of PCP among HIVinfected individuals has decreased in developed
countries, the prevalence of AIDS related PCP
in developing countries remains high and poorly
controlled.
P. jirovecii replicates asexually by binary fission of
trophozoites and sexually, resulting in the formation
of a cyst. Since P. jirovecii is not cultivable in
vitro, the diagnosis of PCP has long relied on
microscopic detection of trophic forms and cysts

using different stains [Giemsa, toluidine blue,
calcofluor white and Gomori methenamine silver].
Overall, the diagnostic performance of conventional
stains is comparable. These staining techniques
are less sensitive and dependent on the skill of the
technologist and patient’s immunosuppression.
These stains were supplanted in the mid-1990s by
direct (DFA) or indirect immunofluorescence assays
(IFA) using anti-P. jirovecii monoclonal antibodies.
The sensitivity of the immunofluorescence assays,
irrespective of the technique used (direct or
indirect),was better than conventional staining. These
staining techniques offer the advantage of easy and
rapid identification of the organism. Preparation
time varies from one to two h. The appearance
of the organism on the smear varies according to
the specificity of the monoclonal antibody. DFA
detects both trophozoites and cysts, whereas IFA
does not detect trophozoites. (Figure 1) Because of
the variability in the appearance of the organism
19
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Figure 1: Detection of P. jirovecii cysts by Indirect immunofluorescence
assay (IFA) (courtesy; Microbiology Section, Department of Pathology
and Laboratory medicine, AKU).

Microscopic diagnosis is particularly difficult when
fungal burdens are low, and thus may be false
negative. Additionally, immuno-fluorescent stains
are limited by reliable quality control material as the
species available as control is Pneumocystis carinii
(animal pathogen), while the target is Pneumocystis
jirovecii, the human pathogen.
Recently polymerase chain reaction (PCR) based
assays for Pneumocystis have been reported to be of
high sensitivity and specificity and are advocated as
new test of choice. Various PCR targets and methods
have been developed , and real-time PCR has
progressively supplanted conventional PCR. PCR
has been reported to enhance PCP diagnosis with
a fourfold increase in case detection compared to
staining techniques.
Owing to the non-specificity of imaging and clinical
signs and the frequent co-infections and noninfectious causes of lung infiltrates, together with
the possible toxicity and the long duration of PCP
therapy, making a PCP diagnosis on clinical criteria
or imaging alone is not recommended and guidelines
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recommend that clinical, radiologic, and other
laboratory findings should be considered together
with the PCR results.
Thus in keeping with the improved diagnostic
standards as per international evidence-based
recommendations, the Aga Khan University
Hospital Laboratories have decided to discontinue
Pneumocystis jirovecii monoclonal fluorescent
antigen test and replace it with Pneumocystis
jirovecii PCR effective from August 1, 2018. This
is a real-time PCR assay for specific detection
of Pneumocystis jirovecii in respiratory samples
specimens including: bronchoalveolar lavage (BAL),
tracheal aspirates and sputum. DNA is extracted from
specimen and is tested by PCR using primers and
probe specific to Pneumocystis jirovecii.(Figure 2)
Amplification
2500
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1500
RFU

and the presence of background fluorescence,
interpretation of these assays also requires a certain
degree of technical expertise and familiarity with the
morphology of the organism.
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Figure 2: Detection P. jirovecii specific DNA by PCR (courtesy;
Molecular Pathology Section, Department of Pathology and Laboratory
medicine, AKU).

Appropriate internal controls and positive
controls are included in the assay. Result
interpretation is based on detection of fluorescent
signals.
Thus timely accurate diagnosis will lead to
appropriate management and avoid unnecessary
extra antibiotics leading to prevent antimicrobial
resistance.
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Microbiology Quiz
Faheem Naqvi
Clinical Microbiology

A 25-years-old male patient who underwent renal
transplant surgery a year before and is on prednisone
10mg/d dose and Mycophenolate mofetil 500 mg
per oral dose twice daily presented with altered
mentation and severe headache for last five days.

On radiologic evaluation a space occupying lesion
of low attenuation was found in frontal area. He
underwent craniotomy and perioperative sample send
for microbiological assessment. Direct microscopic
assessment at X 40 magnification showed following
structure.
Questions:
1.
		
2.
3.
		
4.
		

What is the possible microscopic
identification and diagnosis?
What is the staining technique?
What is the possibility of culture positivity in
this situation?
What incubation temperature, culture plates
and time required for growth?

Histologic Features Of Bacterial
Lymphadenitis Other Than Mycobacteria
Dr Alka Rani
Histopathology

Inflammatory processes of lymph nodes that occur
in response to a variety of pathogenic agents are
viruses, bacteria, fungi, and protozoa. They may
be specific or nonspecific, featuring necrosis,
abscesses, granulomas, and fibrosis in various
combinations. The cellular reactions in each
category are characteristic and contributory to the
histologic diagnosis. Adjuvant diagnostic methods
such as special stains, immunohistochemistry,
and in situ hybridization analysis, and polymerase
chain reaction (PCR) techniques can be used in the
identification of the etiologic microorganisms.
Suppurative Lymphadenitis
Opportunistic bacterial infections can involve
regional lymph nodes and lead to acute
lymphadenitis that may become suppurative.
Infections are often caused by Staphylococcus
aureus and, less often, ‘group A streptococcus’. In

early phases of bacterial lymphadenitis, the nodal
architecture is intact and sinuses are distended by a
pale eosinophilic proteinaceous fluid with numerous
admixed neutrophils and macrophages (sinus
catarrh). Neutrophils eventually form microabscesses
that may enlarge and coalesce to form suppurative
lymphadenitis leading to abscess formation or a
draining sinus. In a later stage, the acute inflammatory
process subsides, and polymorphonuclear leukocytes
are progressively replaced by lymphocytes,
plasma cells, and particularly macrophages
containing ingested cellular debris. Rarely, healed,
late-stage suppurative lymphadenitis appears
xanthogranulomatous. Bacterial colonies may be seen
on histologic sections.
Cat Scratch Disease
Necrotizing granulomatous lymphadenitis caused
by Bartonella henselae. A cat scratch, bite, or lick
21
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introduces the bacteria at the site of cutaneous
inoculation, characterized by granulomatous
inflammation on histological examination of the
lymph nodes. The skin lesion demonstrates a
circumscribed focus of necrosis, surrounded by
histiocytes, often accompanied by multinucleated
giant cells, lymphocytes, and eosinophils.
The regional lymph nodes demonstrate follicular
hyperplasia with central stellate necrosis
with neutrophils, surrounded by palisading
histiocytes (suppurative granulomas) and sinuses
packed with monocytoid B cells, usually
without perifollicular and intrafollicular epithelioid
cells.
Lymphogranuloma Venereum Lymphadenitis
(LGV)
Lymphadenitis caused by the sexually transmitted
bacterium Chlamydia trachomatis. The early
lesions in the lymph nodes consist of accumulations
of neutrophils and small, necrotic foci. Shortly
thereafter, lymphocytes and plasma cells surround
the necrotic foci, which coalesce to form the
typical abscesses of LGV ( stellate or geographic)
and they comprise a central area of necrosis and
polymorphonuclear leukocytes surrounded by a
zone of palisaded epithelioid cells, macrophages,
and multinucleated giant cells . In tissue sections,
the microorganisms stain red to violet (gramnegative, Brown-Hopp), light blue (Giemsa or
hematoxylin and eosin), and black (Warthin-Starry).
The suppurative lesions may form sinus tracts,
which often reach the skin. Electron microscopy
reveals elementary and reticulated bodies and
intermediate forms characteristic of the genus
Chlamydia.

Syphilitic Lymphadenitis
Lymphadenitis in the course of syphilis caused by
infection with Treponema pallidum. Histopathologic
features include marked hyperplasia of the lymphoid
follicle. The lymph node capsule is substantially
broadened by chronic inflammation and fibrosis.
Arteritis and phlebitis affect the numerous, newly
formed vessels of the capsule and pericapsular
tissues, which show wide, perivascular cuffs
of plasma cells and lymphocytes. Proliferation
of plasma cells is extensive, particularly in the
medulla, sometimes resulting in solid cellular sheets.
Scattered, small, usually noncaseating epithelioid
granulomas are sometimes present, whereas at other
times single, multinucleated giant cells, completely
isolated (“naked giant cells”) among the lymphocytes
of the parenchyma, can be seen. Silver staining
with the Warthin-Starry technique or the Levaditi
technique reveals the presence of spirochetes in
the lymph node parenchyma and more often in the
walls of postcapillary venules and capsular vessel.
Immunofluorescent and immunoperoxidase staining
with specific antisera directed against T. pallidum has
successfully demonstrated spirochetes.
Lymphadenitis of Whipple Disease
Lymphadenitis caused by infection with the
bacterium Tropheryma whipplei. The enlarged
lymph nodes comprise large numbers of foamy
mononuclear cells, singly and in loose aggregates,
in the sinuses and lymphoid areas. The cells are
histiocytes containing a PAS-positive, diastaseresistant mucopolysaccharide substance. Tissue
necrosis is absent, and the result of Ziehl-Neelsen
acid-fast staining is negative.

Radiology Pathology Correlation- Orthopedic
Pathology
Dr Nasir Ud Din and Dr Dawar Khan
Department of Pathology and Laboratory Medicine and
Department of Radiology

A 5 year old child presented with history of pain on
wrist of several months duration. Mother noticed
son having low grade fever as well. Complete blood
count (CBC) showed a raised white blood count and
22

a raised erythrocyte sedimentation rate (ESR). An
x-ray of wrist showed soft tissue swelling at the wrist
joint with some erosion and sclerosis of the carpal
bones. Distal radius also shows lytic changes.
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Figure 1: X-ray of AP & Lateral view shows soft tissue swelling with
some erosion and sclerosis of the carpal bones. Distal radius also shows
lytic changes.

A biopsy was performed for primary diagnosis and
to rule out any neoplastic process. Histological
examination of biopsy showed intertrabecular areas
filled with scattered granulomas (Figure 2A). These
were composed of collection of epithelioid histiocytes
and few multinucleated giant cells. Focal necrosis was
seen in the center of granulomas as well. Rare Acid
Fast Bacilli were identified on Ziehl-Neelsen stain
(ZN stain) stain. Fungus stain was negative. Based on
radiological and histological features, a diagnosis of
Tuberculous osteomyelitis was made.

Figure 2: Low & high power magnification showed granulomas
composed of palisaded collection of epithelioid histiocytes (H&E stain)

Pakistan is one of the countries in Asia with high
incidence of tuberculosis. Tuberculous osteomyelitis
is one of the common causes of bone infection
seen in our practice. Bone tuberculosis is usually
spread from active visceral disease. Spine is most
commonly involved followed by hip and knee joints.
Vast majority of spinal tuberculous infection is
centered in the anterior column of T6-L3 leading to
the formation of a gibbous or kyphosis. Any joint
can be involved and females are most affected than
males. Mid-tarsal joints are commonly involved in
foot bones and calcaneum is frequently involved in
tuberculosis of ankle.
Poor socioeconomic status, concurrent respiratory
or intestinal tuberculosis and contact with person
of active disease are predisposing factors. In a local
study, Montoux test was positive in approximately
2/3rd of patients. A raised ESR is typically seen,
although CBC can be normal. Sensitivity of ZN stain
varies as well as those of AFB culture. Diagnosis
is usually made on histological examination of the
affected tissue.
Tuberculous osteomyelitis is usually
hematogenous in origin and is most commonly
seen in bones of the extremities, including the
small bones of the hands and feet. In long, tubular
bones, tuberculosis often involves the epiphyses.
In children, metaphyseal foci can involve
the growth plate. This feature differentiates
tuberculosis from pyogenic infection. The initial
radiologic appearance of tuberculous osteomyelitis
is similar to that of other types of osteomyelitis
and includes foci of osteolysis with varying
degrees of eburnation and periostitis.

Neuro-Radiology and Pathology Correlation
Rhinocerebral Invasive Aspergillosis
Dr Umaima Ayesha Jilani, Dr Shayan Sirat and Dr Sidra Arshad
Department of Pathology and Laboratory Medicine and
Department of Radiology

26 year old gentleman, with no known co-morbid,
presented to the consulting clinic with complain
of headache and reduced vision for the past two
months, which was progressively worsening. On

clinical examination, he was vitally stable and well
oriented.
An MRI was performed which demonstrated a
23
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large infiltrative abnormal signal intensity lesion
arising from the floor of the anterior cranial fossa.
It infiltrated bilateral frontal lobes and genu of the
corpus callosum. There was significant associated
perilesional vasogenic oedema and mass effect with
subfalcine herniation and midline shift. It also resulted
in mass effect on the brain stem along with effacement
of the frontal horns of bilateral lateral ventricles.
It also infiltrated the cribriform plates and showed
extension into the right ethmoid sinus and the right
lamina papyracea, with displacement of the right
medial rectus muscle. Features were supportive of
aggressive mass lesion on imaging.(Figure 1 A and B)

Figure 1:
Tumor like Invasive CNS Aspergillosis: (A) Axial T2WI showing heterogenous low signal intensity lesion in bi-frontal lobe showing (B) intense
enhancement on post contrast T1WI

A neuro-navigation guided craniotomy and
resection of the frontal space occupying lesion was
done. Initially frozen section was done which was
reported as granulomatous inflammation with a
few suspicious filamentous organism, thus ruling
out malignancy. Histological examination of the
frozen and permanent sections showed glial tissue
exhibiting multiple well-formed granulomas; which
were composed of giant cells (Figure 2 A). The usual
differential diagnosis in such cases are Tuberculous
granulomas and fungal infections. Special stain
PAS+/- D was performed and highlighted multiple
branching septate fungal hyphae (Figure 2 B). Thus
a diagnosis of asperigellosis was favoured with
microbiological correlation. Culture also showed
Aspergillus Flavus colonies.

B
Figure 2

Discussion
Aspergillous derives its name from “aspergillum’
a perforated ball for sprinkling holy water, due to
similarity of its fruiting heads with aspergillum.
Aspergillosis of paranasal sinuses affects healthy
and immunocompromised individuals alike. It is
not contagious and source of infection is usually
endogenous.
It has four basic clinic-pathological presentations.
Two of these are saprophytic (Aspergilloma and
allergic aspergillous sinusitis) and two are infectious
(chronic indolent and invasive fulminant sinusitis).
CNS aspergillosis results from angioinvasive
infection of the central nervous system by the fungus
Aspergillus spp. It is one of the most common
fungal opportunistic infections of the central nervous
system, after CNS cryptococcosis.
Tissue invasive and angioinvasive aspergillosis can
be a rapidly fatal diseases.
Epidemiology
The disease predominates in immunocompromised
individuals.
Clinical presentation
Symptoms of cerebral aspergillosis are non-specific
and akin to other CNS infections. These include,
fever, headache, meningeal irritation, nausea/
vomiting, focal neurological deficits, seizures, mental
alteration or lethargy.
Pathology
There are two mechanisms of spread of Aspergillus
spp to the CNS. Firstly, haematogenous spread to
central nervous system. Secondly, direct spread to
the CNS via the paranasal sinuses, where it may
manifest as invasive fungal rhinocerebritis.

A
Figure 2
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Radiographic features
The disease can have a variety of radiographic
presentations, but the main three findings on MRI are:
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Aspergillus abscess and invasive fungal
rhinosinusitis
Cerebritis followed by abscess formation, are often
multiple, present in a random distribution, and
appear radiologically as classic ring-enhancing
lesions with central diffusion restriction, identical
to other brain abscesses. However, aspergillus
abscesses may also have peripheral low signal
intensity on T2-weighted, GRE or SWI images, and
is secondary to surrounding hemorrhage.
In cases where CNS aspergillosis is secondary
to paranasal sinus disease, associated invasive
rhinosinusitis (either acute or chronic), osteomyelitis,
local dural enhancement and subdural empyema may
also be present.
Aspergillus infarction
Infarcts are often multiple, present in a random
distribution, and are radiologically identical to other
ischemic strokes, especially those of perforating
artery territories. Hemorrhage is present in up to 25
percent, and mycotic aneurysms may or may not be
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identified. Infarction and associated hemorrhage are
best ascertained on DWI and SWI sequences.
Tumor-like lesion
Rarely, CNS aspergillosis can present as a
granulomatous tumor-like lesion. These are
often hypo-to-isointense on T1-weighted images,
hypointense on T2-weighted images, and
demonstrate significant contrast enhancement on
post-gadolinium T1-weighted images, but there is
thought to be considerable variation.
Treatment and prognosis
CNS aspergillosis is treated with intravenous
antifungal. Neurosurgical opinion and intervention
may also be sought. In immunocompromised
hosts, which encompasses nearly all cases, it has a
mortality approaching 100 percent if left untreated.
Differential diagnosis
CNS toxoplasmosis, CNS tuberculosis, pyogenic
abscesses, CNS lymphoma, cerebral metastases.

Role of Next Generation Sequencing in
Antimicrobial Drug Resistance Detection and
Monitoring
Dr Najia Ghanchi
Molecular Pathology and Microbiology

With emergence of rapid sequencing technologies,
referred as next-generation sequencing (NGS),
have considerably transformed the way we look at
microbes. NGS enabled us to analyses pathogenic
bacterial genomes, human microbiome and the
environmental microbiota. Microbial whole genome
sequencing (WGS) offers the potential to predict
antimicrobial susceptibility from a single assay.
NGS not only identifies known resistance genes but
also predicts of novel genes linked with resistance,
genomic origin antimicrobial resistance (AMR) and
information on new markers for AMR surveillance.
The introduction of massively parallel DNA
sequencing, NGS revolutionized the field and
allowed hundreds of samples to be analysed
simultaneously. A typical NGS workflow includes
DNA extraction and fragmentation, ligation of
adaptors, amplification and sequencing. There are

several platforms available such as illumina Hiseq
and Miseq, Thermo Ion torrent and Roche GS-FLX
to name few. (Figure 1)

Figure.1 Next generation sequencing Platforms using variable chemistries.

Third-generation sequencing platforms are also
introduced in market such as Oxford nanopore
MinION which is the only portable, real-time device
for DNA and RNA sequencing. It can easily plugged
to laptops and data processing can be monitored in
real time.
After the first bacterial genome sequencing in mid
90’s, whole bacterial genome sequencing (WGS)
25
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has been implemented as
routine diagnostic technique in
developed countries. Bacterial
WGS has emerged as the
ultimate technique for bacterial
outbreak analysis, difficult to
cultivate bacteria or the previous
use of antimicrobial agents
which hinders bacterial growth.
Besides WGS of microbes
the important utility of next
generation sequencing is
clinical metagenomics. It
refers to the application of
Figure 2: Workflow of the application of next-generation sequencing (NGS) in the field of antimicrobial
NGS on clinical samples to
resistance (Adapted from reference 4)
generate information on clinical
relevance, such as the identification of pathogens and
sample or even detect RNA viruses. This approach
prediction antimicrobial susceptibility.
could therefore provide unbiased detection of all
microorganisms present in the sample however this
The prediction of antimicrobial susceptibility for
require lot of data mining and supporting clinical
Mycobacterium tuberculosis has now become routine
information.
and it was made possible due to the highly clonal
nature of the organism, the absence of horizontal
Clinical metagenomics can address the AMR
gene transfers and the very large number of strains
challenge by the rapid identification of pathogens
sequenced providing actionable results much
and parallel prediction of susceptibility to
faster. Indeed, Metagenomics offers the potential
antimicrobials reducing the reporting time from 48
to directly detect all microorganisms present in a
hours to six–eight hours.

Role of Imaging in the Diagnosis and
Management of Hepatic Abscess
Dr Shaista Afzal
Radiology

The most common type of visceral abscess is the
liver abscess and its predominant clinical symptoms
include fever and right upper quadrant abdominal
pain. Liver parenchymal infection resulting in abscess
formation can occur through vessels, biliary channels
or by contiguous spread from adjacent structures.
The multiple etiologies include bile duct lithiasis,
ischemia, cholecystitis, cholangitis, liver transplant /
trauma, intraabdominal collections e.g. secondary to
appendicitis etc. The infection is commonly bacterial,
sometimes parasitic and rarely fungal .In Africa and
South East Asia, the most frequent cause of abscess
is amebic infection while in the Western countries
pyogenic/bacterial abscesses are more prevalent.
26

Imaging plays a crucial role in the diagnosis of
liver abscess, with the sensitivity of ultrasound
(US) and CT reported as 85 percent and 97 percent
respectively. The micro abscess ie less than two
cm appear as hypoechoic nodule or as an ill-defined
area of hepatic parenchyma on US. The larger
abscesses appear as hypo / hyper echoic lesions due
to presence internal echoes resulting from of debris
and thickened septae. Thus, the abscess may appear
as a solid lesion; however the presence of acoustic
through transmission and absence of Doppler flow in
an abscess can help to exclude a solid lesion. (Figure
1a) Though, a solid tumor with extensive necrosis
may be difficult to exclude.
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On CT, the hepatic abscess appears as a well-defined
round mass of low attenuation and enhancing
peripheral rim. These may be single non loculated /
single multiloculated lesions, solid phlegmonous
or may be multiple lesions (Figure 2). The typical
imaging feature of abscess on contrast enhanced
CT is the “double target sign” which represents the
central fluid as low attenuation area surrounded by
high attenuation inner ring representing the pyogenic
membrane and a low attenuation outer ring due to
edema of liver parenchyma (Figure 1b). The other
imaging signs described with liver abscess include
the “cluster sign” i.e. multiple small abscesses
coalesce into one large abscess and the “transient
hepatic hyper enhancement” which occurs due to
compression of small portal venules by the abscess
and compensatory increased arterial flow.
Gas in the form of bubbles or as an air fluid level
may be seen in up to 20 percent of liver abscesses.
On US, the gas within abscess appears as hyper
echoic foci with posterior acoustic shadowing and
reverberations.
The complications of liver abscess include vascular
thrombosis (i.e. of portal vein, hepatic vein, IVC),
rupture (into sub phrenic space, abdominal cavity
etc.) and sepsis.
The mainstay of treatment of liver abscess is antimicrobial therapy and radiological intervention.
Nowadays, the operative intervention is rarely
needed and image guided percutaneous drainage has
been a vital advancement in management.
Image Guided Percutaneous Liver Abscess
Drainage
The reported success rate of this procedure
ranges from 70 to 100 percent and two methods
are employed i.e. percutaneous deployment
of indwelling catheter and needle aspiration.
However better success rate as evident by clinical
improvement and decrease in abscess cavity volume
is reported with catheter drainage especially in
abscess with large volume, partially liquefied or
having thick pus. The pre-requisites for the procedure
includes informed consent and determination of
coagulation factors and in presence of coagulopathy,
correction to acceptable levels is required. The
procedure is performed after all aseptic measures,
under local anaesthesia ie two percent lidocaine with
intravenous analgesics and sedation when needed.
The procedure is performed using freehand technique
under real time ultrasound guidance, an 18 gauge

needle is advanced in liver abscess and contents
aspirated to completely evacuate the cavity if the
abscess is less than three cm in largest dimension.
Percutaneous catheter drainage in indicated for
larger abscesses (Figure 3 a, b, c). An, appropriate
sized catheter i.e. eight to 12 French pigtail can
be introduced in the abscess using the Seldinger
technique and secured to the skin and connected
to a closed collecting system. Catheter removal
is warranted when the patient shows clinical
improvement with relief of symptoms and
normalization of total leucocyte count and when the
follow up ultrasound shows negligible abscess cavity.
The advantages of needle aspirations are being less
expensive, problems related to catheter and long
term hospital care can be avoided and aspiration
of multiple abscesses can be performed in the
same sitting. However, its success rate is lower
than catheter drainage which may lead to repeated
aspirations in a short time period of one to two
weeks. The catheter drainage of abscess provides
continuous drainage of pus and obviates the need for
repeated procedures.
The percutaneous drainage of liver abscess is a safe
technique and few complications are reported like
hemorrhage, persistent drainage of bile, hollow organ
injury, displacement/blockage of catheter, sepsis, pleural
effusion/empyema etc. The possibility of secondary
bacterial infection has been infrequently reported.
Failure of procedure due to thick pus or premature
catheter removal can be avoided by using adequate
gauge catheters and strict protocol should be followed
with respect to flushing and removal of catheters.
Conclusion
Image guided percutaneous drainage is a minimally
invasive, safe, effective and widely preferred
treatment of liver abscess

Figure 1a: US image shows liver abscess in right lobe. It appears as
hypoechoic lesion with posterior enhancement. No vascularity seen
within it on Doppler.
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Figure 1b :CT scan of same patient shows a low attenuation lesion
demonstrating “double target sign” ie central fluid as low attenuation
area surrounded by high attenuation inner ring and a low attenuation
outer ring

Figure 3 a:US shows a large well-defined heterogenous predominantly
hypoechoic lesion without internal vascularity in liver, occupying
segment IV, VIII and part of left lobe. Findings are consistent with liver
abscess

Figure 2 :Multiple well-circumscribed low attenuation lesions scattered
in both lobes of liver. Severely oedematous thick-walled right hemicolon
and cecum.Appearances are suggestive of amoebic colitis with multiple
liver abscesses .The perihepatic fluid represent fluid due to spontaneous
abscess perforation

Figure 3b: CT of the same patient shows large well-defined lowattenuation lesion with peripherally enhancing wall consistent with liver
abscess

Figure 3c:US image shows the liver abscess, accessed with needle (arrow) for catheter placement
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The Best of the Past

Radiologist #Vascularintervention# Followtheirlead
Interview recorded by
Dr. Shayan Anwer

Q. Considering your entire time as an
Intervention radiologist at your organization,
can you recall a time (any AHAA moment) when
you felt most alive or most excited about your
involvement in the organization?
Prof Tanveer ul Haq: I felt a similar emotion at several occasions. In my recollection, certain moments stand
out like when I first started Neurointervention (first
case of brain AVM in 1999) as a first case in Pakistan, a
while back when I received the best section head award
which, in my department, was the first of its kind,
and, when I started the IR fellowship program in 2005
which was the foremost fellowship program in radiology held anywhere in the country. Most importantly,
in 2014, mainly because of my considerable attributes
and achievements in IR, I was promoted to Professor,
which, to me, is the one occasion I consider to be the
real fruit of all my previous efforts.
Q. Please briefly share your initial phase of
journey i.e. from medical graduate to consultant.
Prof Tanveer ul Haq: Initially after the completion
of my house job (1988), I lacked a sense of clarity
regarding my future. Unresolved and uncertain about
what lay ahead, I relied completely on Allah. I delved
into a few peripheral private practices during which
I cleared my FCPS Part 1 exam. Immediately after,
I sprung into internal medicine residency at AKU.
Amidst second year, a realization dawn upon me
that my instincts did not match well with medicine.
Luckily, while I was still in internal medicine, I got
greatly inspired by radiology. This resulted in my
concluding transfer to radiology, following which the
direction was pretty straight forward, with successes
one after the other (Alhamdolillah). I also started
taking a keen interest in IR during my radiology
residency, an area which was very underdeveloped
during that period of time. Due to this, I was sent for
fellowship training in IR to Halifax, Canada and later
the entire journey moved around IR.
Q. Let’s consider for a moment the things you
value deeply. Specifically, the things you value
about yourself and the nature of your work, what
is the single most important thing your work has
contributed to your life?

To “Pursue Excellence” in the field of my choice
Q. As a senior most Intervention radiologist
of the country, please share your experience of
development of Intervention radiology field in
Pakistan and its future in next 10 years.
Prof Tanveer ul Haq: When I first began (1993),
IR was quite in premature shape and we were
considerably lagging behind in this modern era. I
am deeply thankful to AKU and my seniors for their
support and for providing the much needed facilities
and a platform through which advance IR could be
practiced. We therefore, pioneered almost all the
advanced IR techniques and procedures at AKU
within the country, and gradually came at par with
the rest of the world. Our fellowship program has
made a massive impact and now many centers in
Karachi are being led by our ex fellows. The growth
of IR, within the country, was further accelerated
by the launch of national IR society (IRSP), in
2015, which could not have been possible without
AKU’s team effort. I became the first president of
the society. More and more centers are now being
introduced for advance IR practices, and this current
rising pace is indicative of a very bright future for IR
in the next 10 years.
Q. Any advice for Junior Radiologists?
Prof Tanveer ul Haq: Work with honesty, dedication,
passion and pray to Allah, your probability for
success will be much higher. Keep on striving
and never loose heart. Your journey will be full of
achievements if you set targets at the upper extremes.
29
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The Best of the Past

#Microbiologist #Dedication Followtheirlead
Interview recorded by
Dr Mohammad Zeeshan

Q. How long you have been associated with
AKUH
Mr Shahid Ahmed: It feels like yesterday but 31
years have passed since I joined this prestigious
institution
Q. If you could change one thing about AKUH,
what would I be?
Mr Shahid Ahmed: In my opinion workload
distribution and hiring process is not what it used to
be in past, this can make a huge difference in overall
productivity
Q. One thing you like most, about working at AKUH
Mr Shahid Ahmed: Unlike other organizations
AKUH has a strong system in place, so it is not a
single person but the entire system that works this
feature is unique to AKU

Q. What do you like most about your job at
AKUH?

Q. Any memorable event at work from past, that
you still recall?

Mr Shahid Ahmed: A family environment where
everyone cares for each other

Mr Shahid Ahmed: There are many, but I can’t
forget the day when entire hospital was full of
armored persons when one of the prominent political
person was bought to hospital after being shot, we
were confined in hospital premises for many days

Q. What is the difference between past and
present AKUH environment?
Mr Shahid Ahmed: I miss all the greenery and
beautiful landscape that has changed a lot over time

Microbiology Quiz’s Answer
1. Thick-walled, refractile broad ribbon like
aseptate hyphae 6–15 µm in diameter. Possibility
of mucormycosis. Sparse septa can be seen in
mucoreous mold
2. Calcofluor White that bind to chitin present in
the cell wall and fluoresce in ultraviolet light
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3. Sensitivity of culture is not optimal, as only
approximately one third of all microscopically
positive specimens reveal positive cultures.
4. All Mucorales grow rapidly (3–5 days) on most
fungal culture media, such as Sabouraud agar
and potato dextrose agar incubated at 25–30°C
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Polaroid

17th Health Asia – 5th Annual Seminar on Radiology
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Workshop on “Standardized Antimicrobial Susceptibility Testing” conducted in collaboration at Aga Khan University
Hospital in collaboration with “Health Security Partner -HSP” USA, engaging Microbiology technical staff and faculty of
private and public sector from selected institutes across Pakistan.

Dr. Muhammad Shariq Shaikh completed training in multicolour flow cytometry
at the Laboratory Medicine Program,
University Health Network, Toronto. (Back row: third from right)
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Section of Molecular Pathology, Department of Pathology and Laboratory Medicine in
collaboration with the Department of Pediatrics and Child Health held a CME seminar
on “Molecular diagnostics of genetic disorders” on Friday, October 11, 2019 at AKU.
The purpose of the CME was to update on the new molecular diagnostic technologies
available for clinical genetic testing at AKUH. These included genome testing using
chromosomal microarrays, sequencing for thalassemia and other platforms for the first
time in Pakistan. Importance of pre-test counselling and genetic carrier screening were
also highlighted. This seminar was attended by over 200 participants which included
physicians, medical students, and laboratory staff from AKU as well as from other
medical institutions and hospitals. National coverage for participants from AKU Lahore
lab, Shaukat Khanumm hospital and AFIP hospital was also available”.
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A Pre-Conference Half Day Workshop titled ‘Aminoacidopathies from basics to diagnostic caveats’ was conducted
by Section of Chemical Pathology on September 20th, 2019.

A Pre-Conference Half Day Workshop titled ‘Fracture Liasion service’ was conducted by Section of Chemical
Pathology on September 20th, 2019.
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